Journal of the American Academy of Dermatology 2013-12-01

Emerging therapies in rosacea.

Alison Layton, Diane Thiboutot

Index: J. Am. Acad. Dermatol. 69(6 Suppl 1) , S57-65, (2013)

Full Text: HTML

Abstract

Rosacea is a common skin disorder with multiple symptoms. The emergence of research that furthers understanding of pathophysiological mechanisms has created new targets for disease treatment. Specifically, there is a need for new treatments that address the various erythematic symptoms associated with rosacea. Systemic and topical therapies have both yielded positive results in treating rosacea with various medications. Subantimicrobial-dose doxycycline is one such promising treatment. Development of novel products in the near future should help achieve more satisfactory outcomes for patients. Copyright © 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.